Literature DB >> 19329766

Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome.

Min Pu1, Zhaohui Gao, Xueqian Zhang, Duanping Liao, Daniel K Pu, Timothy Brennan, William R Davidson.   

Abstract

The aim of the study was to assess the impact of mitral regurgitation (MR) on left ventricular (LV) anatomic and molecular remodeling and function and to determine whether early LV remodeling and function predict long-term outcome in experimental organic MR. A new rodent model of chronic MR was created. Twenty-eight rats had surgically induced MR, twelve rats had a sham operation, and twelve rats had no operation. LV diameters, volume, and mass and LV ejection fraction (LVEF) and LV fractional shortening (LVFS) were assessed using echocardiography in the early stage of MR (6 and 12 wk after induction of MR). LV hemodynamics was assessed invasively. Cardiac alpha- and beta-myosin heavy chains and sarco(endo)plasmic reticulum Ca(2+)-ATPase 2 (SERCA2) were measured to assess molecular remodeling and contractility. Cox's proportional hazard ratios (HR) were used to identify outcome predictors. Early LV dilation was demonstrated in rats with MR when LVEF and LVFS were still normal. LV remodeling was associated with an increase in LV end-diastolic pressure and decrease in maximal change in pressure over time. Shifting of alpha- to beta-myosin and reduced SERCA2 were observed in rats with MR. Cox's proportional hazard analysis showed that LV end-diastolic diameters (HR, 1.2-2.4; P = 0.007) and LV end-diastolic volume (HR, 1.1-1.4; P = 0.005) at 6 wk and LV mass index (HR, 1.1-2.0; P = 0.004) at 12 wk after induction of MR were significantly associated with 1-yr mortality. However, LVEF (HR, 0.7-6.8 for the 6 wk, P > 0.05; and HR, 0.4-3.2 for the 12 wk, P > 0.05) and LVFS (HR, 0.4-1.4 for the 6 wk; and 0.4-3.1 for the 12 wk, P > 0.05) did not predict late death. Chronic MR leads to LV anatomic and cellular remodeling and impaired contractility. The time course of LV remodeling and function changes in the rat model of MR is similar to humans. Prediction of outcome may be achieved by assessments of early LV remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329766     DOI: 10.1152/ajpheart.00882.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Prognostic value of tissue Doppler-Derived E/e' on early morbid events after cardiac surgery.

Authors:  Leanne Groban; David M Sanders; Timothy T Houle; Benjamin L Antonio; Edi C Ntuen; David A Zvara; Neal D Kon; Edward H Kincaid
Journal:  Echocardiography       Date:  2010-02       Impact factor: 1.724

Review 2.  Myofilament dysfunction as an emerging mechanism of volume overload heart failure.

Authors:  Kristin Wilson; Pamela A Lucchesi
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

3.  Mitral Valve Prolapse: A Disease of Valve and Ventricle.

Authors:  Robert A Levine; Michael Jerosch-Herold; Roger J Hajjar
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

4.  Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis.

Authors:  Kyung-Hee Kim; Yong-Jin Kim; Seung-Pyo Lee; Hyung-Kwan Kim; Jeong-Wook Seo; Dae-Won Sohn; Byung-Hee Oh; Young-Bae Park
Journal:  Korean Circ J       Date:  2011-10-31       Impact factor: 3.243

5.  Prognostic Value of Creatine Phosphate and Inflammatory Markers for Mitral Valve Replacement: A Systematic Review and Meta-Analysis.

Authors:  Yanhui Zhu; Chengwei Zou; Jun Zhang; Lei Chen; Yanting Jia
Journal:  Appl Bionics Biomech       Date:  2022-03-11       Impact factor: 1.781

Review 6.  Experimental models of cardiac physiology and pathology.

Authors:  Jae Gyun Oh; Changwon Kho; Roger J Hajjar; Kiyotake Ishikawa
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

7.  Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve.

Authors:  Jaime Ibarrola; Mattie Garaikoetxea; Amaia Garcia-Peña; Lara Matilla; Eva Jover; Benjamin Bonnard; Maria Cuesta; Amaya Fernández-Celis; Frederic Jaisser; Natalia López-Andrés
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.